Series Vol. 6 , 03 August 2023
* Author to whom correspondence should be addressed.
Abnormal cell growth in the main part of the stomach is what usually leads to gastric cancer. 44% of newly diagnosed gastric cancer cases worldwide occur in China. Overall, gastric cancer is the fourth most common cancer and the second most common cause of cancer death. In recent years, some progress has been made in treating gastric cancer, and it has been found through research that hereditary gastric cancer does exist. The treatment options for gastric cancer will be analyzed and studied in this article. The various stages of gastric cancer will be introduced, along with the various treatment options based on the staging. Through research, early, middle, and late stages of gastric cancer can be distinguished. Early gastroscopy, a CT scan, positron emission tomography, local excision in the middle and late stages, chemotherapy, immunology, and medications for treatment are a few of the treatment options for gastric cancer. Different gastric cancers and patients use various diagnostic and therapeutic approaches depending on the type of cancer they have. Patients can better combat tumor cells and increase their five-year survival rate by using various diagnostic techniques for various time periods. Gastric cancer diagnostic research is anticipated to significantly lower the incidence of the disease with better early detection and chemoprevention for patients.
gastric cancer, recent advance, standard techniques, early gastric cancer
1. Kim, J. J., Lee, J. H., Min, B.-H., & Min, Y. W. (2014). Endoscopic treatment for early gastric cancer. PubMed Central. Retrieved March 1, 2023.
2. Graham, D. Y., & Matsueda, S. (2014, February 21). Immunotherapy in gastric cancer. PubMed Central. Retrieved March 1, 2023.
3. Kume, K. (2014, June 7). Endoscopic therapy for early gastric cancer: Standard techniques and recent advances in ESD. PubMed Central. Retrieved March 1, 2023.
4. Park, C. H., Shim, J. H., Yoo, H. M., Lee, H. H., Song, K. Y., Kim, J. G., & Jeon, H. M. (2011, May 2). Use of laparoscopy as an alternative to computed tomography (CT) and positron emission tomography (PET) scans for the detection of recurrence in patients with gastric cancer: A pilot study. Springer Link. Retrieved March 1, 2023.
5. Wu, C.-X., & Zhu, Z.-H. (n.d.). Diagnosis and evaluation of gastric cancer by positron emission tomography. PubMed Central. Retrieved March 1, 2023.
6. Oliveira, C., Seruca, R., & Carneiro, F. (2009, April). Hereditary gastric cancer. Science Direct. Retrieved March 1, 2023.
7. Guilford, P., Oliveira, C., Carneiro, F., & Van Der PostFátima, R. S. (2019). Hereditary gastric cancer: What's new? Familial Cancer. Retrieved March 1, 2023.
8. Weir, H. K., Jim, M. A., Pinheiro, P. S., Wiggins, C. L., Espey, D. K., & Carreira, H. (2017, December 15). Stomach cancer survival in the united states by race and stage (2001-2009): Findings from the concord-2 study.
9. ACS Jounals. Retrieved March 13, 2023, fromhttps://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.30881
10. Kosaka, T., Kinami, S., Ueda, N., Nakano, Y., Fujita, H., & Funaki, H. (2014, June 24). Local resection of the stomach for gastric cancer. Springer Link. Retrieved March 1, 2023
11. Miyagawa, S., Takeuchi, D., Koide, N., Suzuki, A., Ishizone, S., Shimizu, F., Tsuchiya, T., & Kumeda, S. (2015, October). Postoperative complications in elderly patients with gastric cancer. Science Direct. Retrieved March 1, 2023
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.